---

## Reading Material: An Introduction to Bayesian Inference

---

**Contents**  
I The Bayesian Paradigm 2  
1 A New Way of Thinking: Frequentist vs. Bayesian 2  
II The Engine of Bayesian Inference 3  
2 Bayes’ Theorem and Its Components 3  
3 The Bayesian Workflow in Practice 4

### 1. The Frequentist Foundation: The Long-Run Frequency

To understand why the **Bayesian** approach is such a significant departure, we must first be clear about the **Frequentist** rules we have been following. The Frequentist paradigm defines probability as the limit of an event's relative frequency in an infinite number of trials.

#### The Core Assumptions of the Frequentist Framework

- **Fixed Parameters ($\theta$):** A parameter, such as the true success rate ($p$) of a drug, is viewed as a single, objective, fixed truth. It does not have a probability distribution; it simply _is_.
    
- **Random Samples:** Your data is treated as one random "realization" from a larger process. If you ran the experiment again, you would get different data, leading to a different point estimate.
    
- **Sampling Distributions:** Inference is built on what _would_ happen if you repeated the experiment infinitely. This is why we use p-values and confidence intervals—they describe the behavior of the _procedure_ over the long run, not the probability of the specific result you have in front of you.
    

#### The "Confidence Interval" Nuance

The most common misunderstanding in Frequentist statistics is the interpretation of the **[95% Confidence Interval](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W03 - Estimation And Hypothesis Testing/L0/Statistical%20Inference%20in%20Modelling.md#95-confidence-interval) (CI)**.

- **The Reality:** When you calculate a 95% CI from a single study, you are creating an interval that _belongs_ to a family of intervals. That family has a 95% "success rate" of covering the true parameter over the long run.
    
- **The Misconception:** It is **not** a statement about your specific data. It does not [mean](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W04 - Estimation And Hypothesis Testing Cont/L2/Testing%20Population%20Proportions.md#mean) "there is a 95% probability the true value is in _this_ interval." Once the data is observed, the true parameter is either in the interval or it isn't—the probability is either 0 or 1.
    

#### Why This Works (and Why It's Limited)

The Frequentist approach is the gold standard for clinical trials and regulatory approval precisely because it is **objective**. It doesn't rely on the researcher's beliefs; it relies entirely on the probability of the observed data under a specific [null hypothesis](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W03 - Estimation And Hypothesis Testing/L2/Errors%2C%20P-values%2C%20and%20Significance.md#null-hypothesis).

However, as you move into complex pharmaceutical modeling—where you might have small sample sizes or need to incorporate prior knowledge—this "long-run frequency" requirement can become a limitation. You are often forced to ignore your professional experience because the Frequentist framework has no formal mechanism to "weight" a model with existing domain knowledge.

### Comparison: Defining the Paradigm

|**Concept**|**Frequentist Perspective**|
|---|---|
|**Probability**|Long-run frequency of events.|
|**Parameters ($\theta$)**|Fixed, unknown constants.|
|**Data**|Randomly sampled from a population.|
|**Goal**|Minimize error/bias in the procedure.|
|**Interpretation**|How reliable is the _method_?|

**Strategic Note:** Because Frequentist statistics focuses on the method rather than the specific outcome, it is excellent for standardizing clinical trial results. But when you need to make a specific business prediction (like "What is the probability this specific campaign succeeds?"), the Bayesian approach offers a more intuitive path.

**Since we have established the constraints of the Frequentist world, are you ready to contrast this with the "degree of belief" [definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W01 - Basic Probability & Statistics/L1/Probability%20and%20Distribution.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#definition))))) in the Bayesian paradigm, or would you like to explore how these two approaches handle "uncertainty" differently in a practical scenario?**
### The Bayesian Paradigm: A Shift in Perspective

You have distilled the core of the Bayesian framework perfectly. By shifting the [definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W01 - Basic Probability & Statistics/L1/Probability%20and%20Distribution.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[definition](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#definition))))) of probability from **long-run frequency** to **degree of belief**, you move from asking "how often does this happen?" to "how confident am I that this is true?"

#### 1. Parameters as Random Variables

In the Frequentist world, the "true" parameter (e.g., the exact efficacy of a drug) is a fixed point in the universe, and we are just trying to pin it down with a confidence interval.

In the Bayesian world, **the parameter itself is a random variable**. Because we have imperfect information, we represent our uncertainty about that parameter as a **probability distribution**. This is why we can make direct, intuitive statements like, _"There is a 95% probability the true efficacy is between X and Y."_

#### 2. The Belief-Updating Engine

The process you described—**Prior $\to$ Likelihood $\to$ Posterior**—is essentially a formal mathematical way of "learning."

- **The Prior ($P(\theta)$):** This captures your state of mind before the current evidence. It prevents you from being a "blank slate." It allows you to integrate domain knowledge, past study results, or expert consensus into your model.
    
- **The Likelihood ($P(\text{Data}|\theta)$):** This is the objective data you just collected. It acts as the "refiner."
    
- **The Posterior ($P(\theta|\text{Data})$):** This is your improved, smarter belief. It is the weighted compromise between your initial state of mind and the new, hard evidence.
    

#### Why This "Alternative" is Increasingly Vital

This paradigm is becoming the standard for high-stakes business and scientific decision-making for a few key reasons:

1. **Direct Interpretability:** Stakeholders (like your colleagues Rohit or Kartik) prefer to hear "There is an 80% chance this campaign will be profitable" rather than "The p-value of our hypothesis test is 0.04."
    
2. **Small Data Robustness:** In scenarios where data is scarce (e.g., a rare disease cohort or a new product launch), the **Prior** provides essential stability. It prevents the model from making wild, erratic [predictions](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/The%20Coefficient%20of%20Determination%20%28R%C2%B2%29.md#predictions) based on a small sample size by "anchoring" the estimate to what is already known.
    
3. **Dynamic Learning:** It allows you to build models that grow more accurate over time. As you collect more data, your **Posterior** automatically becomes the **Prior** for the next round of analysis.
    

### Comparison of the Learning Process

|**Phase**|**Action**|**Statistical Goal**|
|---|---|---|
|**Prior**|Encode existing knowledge|Set the baseline belief.|
|**Likelihood**|Process new data|Weigh the new evidence.|
|**Posterior**|Update knowledge|Achieve a more accurate, refined belief.|

**Strategic Note:** Because the posterior distribution is the ultimate goal, the "mathematical engine" (Bayes' Theorem) is just the means to an end. The real power is in the **updating**—the ability to mathematically refine your professional judgment using empirical evidence.

**Since we have a firm grasp of the Bayesian philosophy, would you like to explore the "Beta Distribution"—which is the most common way to represent a Prior for binary (0/1) outcomes—or are you interested in how we use "MCMC" to compute the Posterior when the math becomes too complex to solve by hand?**

### Philosophical Foundations: Frequentist vs. Bayesian

The divide between Frequentist and Bayesian statistics isn't just about formulas; it is about how we define **uncertainty** and the **nature of the parameters** we are trying to estimate.

#### The Frequentist Paradigm: The World of "Long-Run Frequency"

Frequentist statistics is rooted in the idea of repeatability. It assumes the "truth" (the parameter) is a fixed point in the universe, and our data is merely one of many possible random samples we could have collected.

- **Fixed Parameters:** The parameter $\theta$ is a constant. It does not have a probability distribution; it is simply "unknown."
    
- **The Random Data:** The randomness lies in the sampling process. If you were to repeat your experiment 1,000 times, your results would fluctuate.
    
- **The "Confidence" Trap:** A [95% Confidence Interval](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W03 - Estimation And Hypothesis Testing/L0/Statistical%20Inference%20in%20Modelling.md#95-confidence-interval) is often misinterpreted. It does _not_ [mean](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W04 - Estimation And Hypothesis Testing Cont/L2/Testing%20Population%20Proportions.md#mean) there is a 95% chance the true parameter is in your specific interval. It means that if you repeated the experiment infinite times, 95% of those calculated intervals would contain the true parameter.
    

#### The Bayesian Paradigm: The World of "Degree of Belief"

Bayesian statistics flips the Frequentist script. It treats the data you have collected as the only evidence that matters, and the parameter ($\theta$) as a random variable that can be described by a probability distribution.

- **Fixed Data:** Once the experiment is over, the data is concrete and fixed.
    
- **Random Parameters:** Because our knowledge is imperfect, we treat $\theta$ as a distribution of possible values. We start with a "Prior" belief and update it with the data (the "Likelihood") to get a "Posterior" distribution.
    
- **The "Credibility" Advantage:** A 95% Credible Interval has the intuitive meaning most people _wish_ Frequentist intervals had: there is an actual 95% probability that the parameter lies within that range, given the specific data you have observed.
    

#### Philosophical Comparison [Summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W01 - Basic Probability & Statistics/L2/Reading%202%20Parametric%20vs.%20Non-Parametric%20Methods.md#[summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W07 - Multiple Regression/L0/Module%207%20Introduction%20-%20Multiple%20Linear%20Regression.md#[summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W07 - Multiple Regression/L1/The%20Multiple%20Regression%20Model.md#summary)))

|**Concept**|**Frequentist**|**Bayesian**|
|---|---|---|
|**Perspective**|Objective / Frequency-based|Subjective / Belief-based|
|**Parameter $\theta$**|Fixed, unknown constant|Random variable (distribution)|
|**Role of Data**|Random samples from a population|Observed evidence|
|**Main Output**|p-values / Confidence Intervals|Posterior distributions / Credible Intervals|

### [Why this matters for your work](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W10 - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis - Cluster Analysis/L1/An%20Introduction%20to%20Cluster%20Analysis.md#why-this-matters-for-your-work)

In your role as a pharmaceutical data analyst, the Bayesian "Credible Interval" is often much easier to explain to clinical leads or business stakeholders than the Frequentist "Confidence Interval."

When you report that **"there is a 95% probability that the drug's success rate is between 60% and 70%,"** you are providing a direct, actionable [answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#answer))) to a decision-maker. In contrast, a Frequentist report saying, **"If we conducted this trial infinite times, 95% of the intervals would contain the true rate,"** is mathematically precise but professionally abstract.

**Now that we have distinguished the two schools of thought, would you like to discuss how to construct a "Prior" distribution to represent your initial beliefs, or should we look at how to use MCMC to calculate those credible intervals in practice?**

## Part II

### 2. The Engine of Bayesian Inference: Bayes’ Theorem

At the heart of the Bayesian approach is **Bayes’ Theorem**. It is not just a [formula](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Testing%20for%20Significance%20in%20Regression.md#formula); it is a mathematical rule for **rational belief updating**. It dictates exactly how we should change our confidence in a hypothesis after we observe new, empirical evidence.

#### The Anatomy of the Theorem

Each component in the equation $P(\theta|\text{Data}) = \frac{P(\text{Data}|\theta) \cdot P(\theta)}{P(\text{Data})}$ serves a distinct role in the learning process:

- **$P(\theta|\text{Data})$ (The Posterior):** This is our **updated belief**. It is the probability distribution of the parameter ($\theta$) _after_ we have taken the current evidence into account.
    
- **$P(\text{Data}|\theta)$ (The Likelihood):** This is the **data's voice**. It is the probability of having observed the data we actually collected, assuming a specific parameter value ($\theta$) were true. It acts as the "weight" that pulls our prior belief toward the empirical evidence.
    
- **$P(\theta)$ (The Prior):** This is our **initial belief**. It encodes what we knew _before_ observing the current data. It might be based on historical clinical data, expert opinion, or a general assumption (e.g., an uninformative uniform prior).
    
- **$P(\text{Data})$ (The Evidence/Marginal Likelihood):** This is the **normalizing constant**. It represents the probability of observing our data across _all_ possible values of $\theta$. Since it doesn't depend on $\theta$, it acts as a "scale" that ensures the final posterior distribution is a valid probability density that integrates to 1.
    

#### The "Updating" Logic

The power of this theorem lies in the multiplication of the **Prior** and the **Likelihood**.

1. If the **Prior** is very strong (a narrow, peaky distribution), the **Likelihood** needs a massive amount of data to significantly shift the **Posterior**.
    
2. If the **Prior** is weak (a flat, spread-out distribution), the **Likelihood** dominates, and the **Posterior** will look almost exactly like the evidence provided by the data.
    

#### The Computational Reality

While the [formula](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Testing%20for%20Significance%20in%20Regression.md#formula) is elegant, it is often difficult to compute $P(\text{Data})$—the evidence—because it requires integrating over all possible values of $\theta$ (the denominator $\int P(\text{Data}|\theta)P(\theta)d\theta$). This is why modern Bayesian analysis relies on **Markov Chain Monte Carlo (MCMC)** simulations, which allow us to estimate the shape of the posterior distribution without needing to solve the complex integral in the denominator directly.

### Comparison of Roles in the Learning Cycle

|**Term**|**Role**|**Why it is critical**|
|---|---|---|
|**Prior**|The starting point|Incorporates previous knowledge.|
|**Likelihood**|The evidence|Represents the current observed truth.|
|**Posterior**|The conclusion|The synthesis of past and present.|
|**Evidence**|The scaler|Ensures mathematical validity (sums to 1).|

**Strategic Note:** In your work as a pharmaceutical data analyst, this is how you update your models as clinical trials progress. You start a study with a prior based on Phase 1 data, and as each patient outcome (likelihood) is observed, you compute the posterior, which immediately becomes the new prior for the next stage of the study.

**Would you like to move into the "Prior Distributions" (such as the Beta distribution) to see how we mathematically encode our beliefs, or are you interested in how MCMC simulation "walks" through a model to find the posterior without needing to calculate the Evidence directly?**

### The Anatomy of Bayes' Theorem: Updating Beliefs

You have identified the four pillars of Bayesian inference. These terms aren't just variables; they represent the **cognitive journey** of moving from uncertainty to evidence-based knowledge.

#### 1. The Posterior: The Destination ($P(\theta|\text{Data})$)

This is your **"Updated Belief."** It is the final synthesis of what you knew _before_ and what you learned _during_ the experiment. Unlike a single "point estimate" in Frequentist statistics, the posterior is a full distribution that tells you not just the most likely value, but the entire range of possibilities and how much credibility to assign to each.

#### 2. The Likelihood: The Evidence ($P(\text{Data}|\theta)$)

As you noted, this is the same Likelihood function we used in MLE. It is the "objective" component of the equation, representing the data’s voice. It tells the model: _"Given a specific parameter value, how likely is it that we would see the data we currently have?"_

#### 3. The Prior: The Foundation ($P(\theta)$)

This is the most distinct part of Bayesian inference. It represents your **"State of Knowledge"** before the current data was collected.

- **If you have an Informative Prior:** You are essentially saying, "I have past experience/studies that suggest the parameter is around this value."
    
- **If you have an Uninformative Prior:** You are saying, "I am open-minded; let the data drive the posterior."
    

#### 4. The Evidence (Marginal Likelihood): The Normalizer ($P(\text{Data})$)

This acts as a **scaling factor**. Because the posterior must be a valid probability distribution (meaning its total area must equal 1), the Evidence ensures that the final result remains within the bounds of probability.

- **The "Proportional" Shortcut:** In many real-world applications, calculating the integral $\int P(\text{Data}|\theta)P(\theta)d\theta$ is computationally expensive or impossible. Because $P(\text{Data})$ does not depend on $\theta$, we often treat it as a constant and simply solve for the shape of the posterior:
    
    $$\text{Posterior} \propto \text{Likelihood} \times \text{Prior}$$
    

### The Bayesian Learning Process

The beauty of this framework is its **recursive nature**. Today's **Posterior** (our final belief) can become tomorrow's **Prior** when new data arrives.

|**Component**|**Role**|**Analogy**|
|---|---|---|
|**Prior**|Baseline knowledge|Your initial guess.|
|**Likelihood**|Current evidence|The facts you observe.|
|**Posterior**|Updated knowledge|Your improved, informed conclusion.|

**Strategic Note:** In pharmaceutical analytics, this workflow is exceptionally powerful for **adaptive clinical trials**. You can start a trial with a "prior" based on Phase 1 data, and as each new patient's results (likelihood) come in, you update your "posterior" to determine if the drug is showing enough promise to continue, potentially saving time and resources.

**Now that you understand the components of Bayes' Theorem, would you like to see how we choose a "Prior" distribution (like the Beta distribution) to represent our initial beliefs, or would you like to discuss why the Marginal Likelihood ($P(\text{Data})$) is often so difficult to calculate in complex, high-dimensional models?**
  
![[Pasted image 20260523111404.png]]

_Figure 1:_ A visual representation of how a flat prior belief is combined with the likelihood from the data (peaked at 0.8) to form a posterior distribution that is a compromise between the two.

### 3. The Bayesian Workflow: From Belief to Evidence

The Bayesian workflow is a cyclical process of **Refinement**. Unlike Frequentist statistics, which treats the analysis as a "one-and-done" test, Bayesian inference encourages you to treat your model as a living entity that learns as new data arrives.

#### Step 1: Model and Prior Selection

This is where the Bayesian approach incorporates **Domain Expertise**.

- **The Likelihood:** This represents the process generating your data (e.g., a [Binomial distribution](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W01 - Basic Probability & Statistics/L1/Probability%20and%20Distribution.md#binomial-distribution) for patient outcomes).
    
- **The Prior ($P(\theta)$):** This is the "secret sauce." If you are analyzing a drug efficacy trial and have data from a pilot study, you can encode those results into a **Prior Distribution**.
    
    - _Informative Prior:_ You have strong, prior data (e.g., a Beta distribution centered on 0.8).
        
    - _Uninformative (Flat) Prior:_ You have no idea what the result will be, so you use a distribution that lets the data "speak for itself."
        

#### Step 2: Calculating the Posterior

We use **Bayes' Theorem** to merge our Prior and our Likelihood. The posterior is the compromise between what you _thought_ and what you _saw_.

- **Analytical Solutions:** In rare cases (like the Beta-Binomial conjugate pair), the math simplifies perfectly, and we can calculate the result by hand.
    
- **Computational Methods (MCMC):** For complex pharma models with dozens of variables, the calculus becomes impossible to solve directly. We use **Markov Chain Monte Carlo (MCMC)**—a simulation method that "walks" through the distribution to map out the Posterior shape. It is essentially an algorithmic way to draw thousands of samples from the Posterior distribution to see what it looks like.
    

#### Step 3: Summarize and Interpret

The output of your model is not a single number or a p-value—it is an **entire probability distribution**.

- **Credible Intervals:** Instead of the Frequentist "Confidence Interval," you get a **95% Credible Interval**. This has the intuitive meaning that we _actually_ believe there is a 95% probability the true parameter lies within this range.
    
- **Point Estimates:** You can report the [Mean](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W04 - Estimation And Hypothesis Testing Cont/L2/Testing%20Population%20Proportions.md#mean), Median, or Mode of your posterior distribution as your "best guess."
    

### The Bayesian Workflow [Summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W01 - Basic Probability & Statistics/L2/Reading%202%20Parametric%20vs.%20Non-Parametric%20Methods.md#[summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W07 - Multiple Regression/L0/Module%207%20Introduction%20-%20Multiple%20Linear%20Regression.md#[summary](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W07 - Multiple Regression/L1/The%20Multiple%20Regression%20Model.md#summary)))

|**Step**|**Action**|**Business Value**|
|---|---|---|
|**Model/Prior**|Inject domain knowledge|Uses past experience to improve current accuracy.|
|**Computation**|Run MCMC simulations|Handles high-dimensional, complex real-world data.|
|**Posterior**|Evaluate the distribution|Provides a clear "probability of success" for management.|

**Strategic Note:** Because the output is a distribution, you can [answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[answer](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#answer))) "What is the probability that the drug efficacy is greater than 50%?" directly by simply measuring the area under the posterior curve above 0.5. This is often the specific [question](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[question](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#[question](https://github.com/Balasubramanian-pg/MSC.-Data-Science-AI/blob/main/Trimester%201/Statistical%20Modelling%20%26%20Inferencing/W06 - Simple Linear Regression/L2/Residual%20Analysis.md#question))) leadership (like Rohit or Kartik) wants to know, and it's something standard frequentist p-values cannot directly provide.

**Would you like to move into the "Prior Distributions" (such as the Beta distribution) to see how we mathematically encode our beliefs, or are you interested in how MCMC simulation "walks" through a model to find the posterior?**

Tags: #statistics #machine-learning #data-science #statistical-modelling